Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ProQR Therapeutics N.V.PRQR · Entity 5946 | Director · Chief Executive Officer | July 31, 2026 | August 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ProQR Therapeutics N.V.
Report date July 31, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 500,000 |
Reported balance
After 2026-07-31 transaction · row 1
1 source rowRow 1 · 2026-07-31 · Purchase · Acquired 200,000 · Balance 500,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 3, 2026 20:01 UTC | ProQR Therapeutics N.V. PRQR · Entity 5946 | PurchaseOrdinary Shares | 200,000 | $1.77 | $353,960.00 |
DisclosureSEC source: 0001104659-26-089780 · tm2622051-1_4seq1.xml · nonDerivative · entry 1 de Boer Daniel Anton · CIK 0002117546 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 12:00 UTC | ProQR Therapeutics N.V. PRQR · Entity 5946 | PurchaseOrdinary Shares | 150,000 | $1.74 | $261,000.00 |
DisclosureSEC source: 0001104659-26-082890 · tm2620241-1_4seq1.xml · nonDerivative · entry 1 de Boer Daniel Anton · CIK 0002117546 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Read SEC document |
| July 07, 2026 Filed Jul 8, 2026 18:55 UTC | ProQR Therapeutics N.V. PRQR · Entity 5946 | PurchaseOrdinary Shares | 150,000 | $1.59 | $238,500.00 |
DisclosureSEC source: 0001104659-26-081762 · tm2620064-1_4seq1.xml · nonDerivative · entry 1 de Boer Daniel Anton · CIK 0002117546 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.